Gland Pharma to invest INR 400 cr to expand its Telangana plant

Gland Pharma announced that it would be investing INR 400 cr to create additional capabilities in its existing facility at Genome Valley  to manufacture biologicals, biosimilar, antibodies and recombinant Insulin.